Skip to main content
. 2020 Aug 14;21(10):56–62. doi: 10.1002/acm2.13004

Table 3.

Treatment characteristics.

Characteristics n (%)
No. Treated lesions 109
Dose Fractionation (Total Dose in Gy/fractions)
50/5 65 (60)
54/3 29 (26)
60/5 10 (9)
48/4 2 (2)
40/5 3 (3)
Tumor Location
Central 13 (12)
Peripheral 96 (88)
Treatment Time
Median days (range) 11 (3‐24)